News
Cabometyx ® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tum ...
6h
InvestorsHub on MSNBiovie shares climb as Alzheimer’s drug shows promising age deceleration effectsBiovie Inc (NASDAQ:BIVI) shares surged 7.3% after unveiling encouraging results for its Alzheimer’s treatment bezisterim at a ...
The clinical-stage biotech company revealed that bezisterim demonstrated significant biological age deceleration in Alzheimer’s disease patients compared to placebo in its Phase 3 study. After 30 ...
IPF treatment candidate CS014 was safe and well tolerated in volunteers in a Phase 1 trial, and showed early promise for ...
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the 13 Best Low Risk High Growth Stocks to Buy. Analysts are reiterating their Buy rating for the stock amid advancements in ovarian cancer ...
Platinum diselenide (PtSe2) is a two-dimensional multilayer material in which each layer is composed of platinum (Pt) and ...
A Bayesian decoder was employed to calculate the posterior probabilities of all position bins. This method assumes that transient counts follow a Poisson distribution and combines transient counts and ...
According to a recent exploratory study published in eGastroenterology, the answer is more complex than expected. Researchers from KU Leuven and collaborating institutions conducted a tightly ...
Platinum selenaide is a two-dimensional material formed by the layered combination of platinum (Pt) and selenium (Se). Its ...
Renesas Electronics Corporation has introduced the RA2T1 microcontroller (MCU) group based on the Arm Cortex-M23 processor optimized for motor control systems. RA2T1 devices are specifically designed ...
As Wall Street awaits key phase III data from Abivax SA with microRNA-124 (miR-124)-targeting obefazimod in ulcerative colitis, due this quarter, the inflammatory bowel disease (IBD) space – which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results